Zazove Associates Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SKINW
The Beauty Health Company Warrant expiring 5/4/2026
SKINW
|
+$2.77M |
| 2 |
RVNC
Revance Therapeutics, Inc.
RVNC
|
+$2.52M |
| 3 |
GDL
GDL Fund
GDL
|
+$1.83M |
| 4 |
ALIT.WS
Alight Inc Warrants
ALIT.WS
|
+$1.72M |
| 5 |
Theravance Biopharma
TBPH
|
+$1.03M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
STEM.WS
Stem, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise pri
STEM.WS
|
+$3.56M |
| 2 |
CLOVW
Clover Health Investments, Corp. Warrants
CLOVW
|
+$3.26M |
| 3 |
FIRY
Firy Inc
FIRY
|
+$3.26M |
| 4 |
EVV
Eaton Vance Limited Duration Income Fund
EVV
|
+$2.88M |
| 5 |
Nuveen Credit Strategies Income Fund
JQC
|
+$1.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 1.97% |
| 2 | Energy | 1.13% |
| 3 | Real Estate | 0.98% |
| 4 | Healthcare | 0.6% |
| 5 | Industrials | 0.02% |
Similar funds
Zazove Associates's Q3 2021 Portfolio in Review
As of Q3 2021, Zazove Associates held 164 positions worth $1.14B, up 2.6% from $1.11B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Zazove Associates withdrew a net $895M in Q3 2021, closing 11 positions and reducing 3 holdings. Its most notable exit was Stem, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise pri, an estimated $3.56M position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 2% of assets, up from 1.9% a quarter earlier, followed by Energy and Real Estate.
Against the trend, Zazove Associates opened a new position in The Beauty Health Company Warrant expiring 5/4/2026 worth $3.73M.
- Zazove Associates's largest Q3 2021 buy was The Beauty Health Company Warrant expiring 5/4/2026: 258,380 shares worth $3.73M.
- Zazove Associates added most to Revance Therapeutics, Inc. in Q3 2021, an estimated $2.52M increase.
- Zazove Associates's biggest Q3 2021 reduction was Hostess Brands, Inc. Warrants, cutting an estimated $1.89M.
- Zazove Associates fully exited Stem, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise pri in Q3 2021, selling an estimated $3.56M.
- Zazove Associates's ten largest holdings make up 41% of its $1.14B portfolio in Q3 2021.
- Zazove Associates opened 10 new positions and closed 11 in Q3 2021.
- Zazove Associates's portfolio value rose 2.6% quarter-over-quarter to $1.14B.
Based on Zazove Associates's 13F filing for Q3 2021, filed 25 Oct 2021.